This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Spanish Society of Health Economics | |
|---|---|
| Name | Spanish Society of Health Economics |
| Formation | 1990s |
| Type | Professional association |
| Headquarters | Madrid |
| Region served | Spain |
| Language | Spanish |
| Leader title | President |
Spanish Society of Health Economics is a professional association dedicated to the study and promotion of health economics in Spain, linking scholars, analysts, and policymakers from diverse institutions such as Carlos III Health Institute, Universidad Complutense de Madrid, Instituto de Salud Carlos III, Ministry of Health (Spain), and European Commission. Founded during a period of expansion in European health policy networks contemporaneous with organizations like European Health Economics Association, International Health Economics Association, World Health Organization, Organisation for Economic Co-operation and Development, and European Observatory on Health Systems and Policies, it serves as a focal point connecting researchers affiliated with Universitat Pompeu Fabra, University of Barcelona, Autonomous University of Barcelona, University of Valencia, and University of Granada.
The society emerged in the 1990s amid policy reforms influenced by actors such as José María Aznar, Felipe González, European Union, Council of Europe, World Bank, IMF, and the policy debates following directives like the General Health Law (Spain), with early meetings involving scholars from London School of Economics, Harvard School of Public Health, Johns Hopkins Bloomberg School of Public Health, University of York, and Université Paris 1 Panthéon-Sorbonne. Founding members included academics linked to Instituto de Estudios Fiscales, Fundación Ramón Areces, Banco de España, and policy advisors who had worked with commissions such as the Beveridge Committee in analogical discussions. Over time, the society formalized statutes, elected boards resembling governance models from Royal Statistical Society, Econometric Society, and established links to national institutions like Consejo Superior de Investigaciones Científicas and regional health services such as Servicio Madrileño de Salud and Servicio Andaluz de Salud.
The society’s mission aligns with objectives advocated by bodies like European Medicines Agency, Comisión Nacional de los Mercados y la Competencia, Spanish Agency for Medicines and Health Products, Institute for Fiscal Studies (UK), and OECD Health Division: to promote rigorous health economic analysis, inform policy debates, and foster interdisciplinary collaboration among researchers from Università Bocconi, Karolinska Institutet, University of Copenhagen, University of Amsterdam, and Helsinki University Hospital. Core objectives emphasize dissemination alongside institutions such as Fundación IDIS, Red de Agencias de Evaluación de Tecnologías Sanitarias, Agencia de Calidad y Evaluación Sanitarias de Andalucía, and networking with think tanks like Elcano Royal Institute.
Membership draws academics, analysts, and practitioners affiliated with institutions including Hospital Universitario La Paz, Hospital Clínic de Barcelona, Quirónsalud, Rovira i Virgili University, University of Santiago de Compostela, and consultancy firms that have worked with McKinsey & Company, Boston Consulting Group, KPMG, and PwC Spain. Governance follows an elected board model with roles akin to boards in Spanish Society of Public Health, Sociedad Española de Cardiología, and Spanish Pharmacological Society, with committees coordinating ethics, education, and research partnerships with bodies such as European Centre for Disease Prevention and Control, National Institute for Health and Care Excellence, and Spanish Agency for Food Safety and Nutrition.
Programs encompass training workshops, policy briefings, and methodological seminars similar to offerings by European School of Health Economics, Health Technology Assessment International, Agency for Health Research and Quality, and capacity-building initiatives with regional governments like Junta de Andalucía and Generalitat de Catalunya. Activities include specialized courses in health economics methods, economic evaluation, and outcomes research, often hosted at venues such as Palacio de Congresos de Madrid, CosmoCaixa, and university campuses tied to Universidad Autónoma de Madrid and Universitat de València.
The society supports scholarly output in journals and working paper series that interact with publications like Health Economics, The Lancet, BMJ, European Journal of Health Economics, and PharmacoEconomics. It promotes research on topics connected to policy debates involving Carta Magna (Spain), Ley General de Sanidad, Royal Decree, and evaluations of interventions funded by programs such as Horizon Europe, Erasmus+, and national research grants from Agencia Estatal de Investigación. Collaborative research often involves centers like Barcelona Institute for Global Health, Instituto de Salud Pública de Navarra, and international partners including Imperial College London and University of Toronto.
Annual conferences attract presenters from linking institutions such as European Commission Directorate-General for Health and Food Safety, World Bank Health Nutrition and Population, International Monetary Fund, Institute for Health Metrics and Evaluation, Royal Society, and leading universities across Europe and the Americas. Events feature plenaries, panels, and poster sessions with participation by public health agencies, hospital administrators, and representatives from pharmaceutical companies including Roche, Novartis, Pfizer, and GlaxoSmithKline.
The society collaborates with entities such as Spanish Society of Epidemiology, Spanish Society of Public Health and Health Management, Federación de Asociaciones Científico Médicas Españolas, European Observatory on Health Systems and Policies, Health Technology Assessment Network (RedETS), and international consortia that advise on health financing, cost-effectiveness, and prioritization. Its impact appears in policy briefs cited by regional health ministries, health technology assessment reports, and academic citations in works by scholars from University College London, Yale School of Public Health, and Columbia University, contributing to debates on reimbursement, pricing, and access to medicines in Spain and beyond.
Category:Professional associations based in Spain Category:Health economics